Merck’s Keytruda wins FDA approval as combination therapy for kidney cancer
US FDA has given approval to Merck's cancer therapy, Keytruda, as part of a combination therapy for previously untreated patients…
Author
Sanjay Murdeshwar of AstraZeneca chosen by Novartis to lead its India business
Murdeshwar, currently the Global Vice President, Cardio-Renal business at Astrazenec, has been picked by the Swiss company to head…
Second death in Novartis gene therapy trials under investigation
Novartis said investigation is underway into whether a second trial death could be related to its experimental gene therapy…
Ministry of AYUSH in MoU with CSIR
Under the MoU, both the organisations will jointly pursue R&D covering fundamental research
Cipla appoints Dr Raju Mistry as President and GCPO
In her role at Cipla, Mistry will oversee human resources, and administration and facilities management
USFDA gives Alembic Pharma a nod for conjunctivitis treatment drug
The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA)…
Novo Nordisk and Gilead team up to test fatty liver disease treatment
The two pharma firms will run combined clinical trials to treat NASH disease
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
A study, being carried out by the companies to test the effectiveness of lower doses of tanezumab for osteoarthritis, reported…
Cipla’s Yusuf Hamied recieves Honorary Fellowship of the Royal Society, UK
Cipla's chairman among the 51 experts elected as Honorary Fellows by the Royal Society of London for the year 2019
Dr Yusuf…
Aurobindo recalls 88k Lidocaine injections from US
The company recalled them due to the presence of a hair strand
Aurobindo Pharma has initiated recall of 88,600 vials of Lidocaine…